DOP Session 10

  • 17:20-18:20 Digital Oral Presentation Session 10 - Microbes, food and cancer in IBD
    Room: Lehar 4, Ground Floor, Congress Centre
    Chairs:
    Gionata Fiorino, Milan, Italy
    Arie Levine, Tel Aviv, Israel
      17:20-17:26 DOP082: Potential diagnostic biomarkers of Ulcerative Colitis-associated colorectal dysplasia
    A.-M. Merli1, C. Massot1, 2, N. Bletard3, F. Quesada Calvo1, D. Baiwir4, G. Mazzucchelli5, N. Smargiasso5, L. Servais6, C. Oury6, M.-C. De Pauw-Gillet7, E. De Pauw5, C. Coimbra Marques8, A. Colard9, A. Vijverman10, P. Delvenne3, M.-A. Meuwis1, 2, E. Louis1, 2
    1. GIGA-R, ULiège, Translational Gastroenterology, Liège, Belgium
    2. CHU de Liège, Hepato-Gastroenterology and Digestive oncology, Liège, Belgium
    3. CHU de Liège, Pathological anatomy and cytology, Liège, Belgium
    4. GIGA proteomic facility, ULiège, Liège, Belgium
    5. ULiège, Laboratory of mass spectrometry, Chemistry, Liège, Belgium
    6. GIGA-R, ULiège, Laboratory of Thrombosis and Hemostasis, Liège, Belgium
    7. ULiège, Mammalian cell culture laboratory, Liège, Belgium
    8. CHU de Liège, Abdominal Surgery Department, Liège, Belgium
    9. CHC de Liège, Gastroenterology, Liège, Belgium
    10. CHR Citadelle de Liège, Gastroenterology and Digestive oncology, Liège, Belgium
      17:26-17:32 DOP083: The association of appendectomy and colorectal cancer in Ulcerative Colitis patients: A systematic review and meta-analysis
    M.E. Stellingwerf, M.A. de Koning, W.A. Bemelman, G.R. D'Haens, C.J. Buskens
    Academic Medical Center (AMC), Department of Surgery, Amsterdam, Netherlands
      17:32-17:38 DOP084: Toll-interacting protein promotes colitis-associated cancer by regulating immune cell infiltration
    C. Begka1, S. Ragusa2, Y. Pu3, C. Mooser4, K. McCoy4, T. Petrova2, M.H. Maillard1
    1. Service of Gastroenterology and Hepatology, CHUV, University of Lausanne, Lausanne, Switzerland
    2. Department of Oncology, CHUV, University of Lausanne, Lausanne, Switzerland
    3. Institute of Pathology, CHUV, Lausanne, Switzerland
    4. Clinic for Visceral Surgery and Medicine, Department of Gastroenterology; University Hospital Bern Inselspital, Bern, Switzerland
      17:38-17:44 DOP085: Innate mesenchymal MyD88 signals promote spontaneous intestinal tumourigenesis
    V. Koliaraki1, A. Henriques1, N. Chalkidi1, A. Polykratis2, M. Pasparakis2, G. Kollias1, 3
    1. BSRC "Alexander Fleming", Vari, Greece
    2. University of Cologne, Institute of Genetics, Cologne, Germany
    3. University of Athens, School of Medicine, Athens, Greece
      17:44-17:50 DOP086: Low FODMAP diet improves functional-like gastrointestinal symptoms but reduces bifidobacteria and faecalibacterium prausnitzii in Quiescent Inflammatory Bowel Disease: A randomised controlled trial and metagenomic analysis
    S. Cox1, A. Stagg2, S. Fromentin3, D. Ehrlich3, 4, N. McCarthy2, N. Galleron3, F. Levenez3, M. Lomer1, 5, J. Lindsay2, 6, P. Irving7, K. Whelan1
    1. King's College London, Nutritional Sciences, London, United Kingdom
    2. Queen Mary University of London, Centre for Immunobiology, London, United Kingdom
    3. Institut National de la Recherche Agronomique, Microbiology, Paris, France
    4. King's College London, Dental Institute, London, United Kingdom
    5. Guy's and St Thomas' NHS Foundation Trust, Nutrition and dietetics, London, United Kingdom
    6. Barts Health NHS Trust, Gastroenterology, London, United Kingdom
    7. Guy's and St Thomas' NHS Foundation Trust, Gastroenterology, London, United Kingdom
      17:50-17:56 DOP087: The gut microbiota of pregnant women with Crohn´s Disease and their babies is associated with abnormalities in the adaptive immune system – results from the MECONIUM study
    J. Torres1, 2, A. Seki3, L. Tarassishin4, J. Hu4, C. Eisele4, N. Nair4, G.J. Britton3, 5, Q. Mao4, I. Mogno3, 5, J.C. Clemente3, 4, J. Faith4, J.-F. Colombel1, S. Mehandru1, 3, I. Peter4
    1. Icahn School of Medicine at Mount Sinai, Gastroenterology, New York, United States
    2. Hospital Beatriz Ângelo, Gastroenterology, Loures, Portugal
    3. Icahn School of Medicine at Mount Sinai, Precision Immunology Institute, New York, United States
    4. Icahn School of Medicine at Mount Sinai, Department of Genetics and Genomic Sciences, New York, United States
    5. Icahn School of Medicine at Mount Sinai, Institute for Genomics and Multiscale Biology, New York, United States
       17:56-18:02 DOP088: Microbial dysbiosis increases experimental colitis by interfering with short-chain fatty acid dependent mucosal Reg3B expression
    D. Bajic1, A. Su1, K. Hillmer1, R. Mejias-Luque2, S. Bluemel3, M. Docampo4, R. Schmid1, B. Schnabl3, M. van den Brink4, M. Gerhard2C. Stein-Thoeringer1, 4
    1. Klinikum rechts der Isar, II. Med. Klinik, Munich, Germany
    2. Institute of Med. Microbiology, TUM, Munich, Germany
    3. University of California, San Diego, San Diego, United States
    4. Memorial Sloan Kettering Cancer Center, New York, United States
      18:02-18:08 DOP089: Individualized variations in the gut microbiota during remission precede Crohn's Disease flares
    T. Braun1, A. Di Segni1, S. Neuman1, N. Levhar1, M. Bubis1, O. Picard1, M. BenShoshan1, G. Efroni1, S. Farage Barhom1, E. Glick Saar1, A. Lahad1, D. Shouval1, B. Weiss1, A. Lahat1, R. Eliakim1, S. Ben-Horin1, U. Kopylov1, The Leona M. and Harry B. Helmsley Charitable Trust supported Israeli IBD Research Nucleus (IIRN), Y. Haberman1, 2
    1. Sheba Medical Center, Tel Hashomer, Israel
    2. Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, United States
      18:08-18:14 DOP090: Risk factors for bacteremia in hospitalized patients with Inflammatory Bowel Disease
    I. Goren1, 2 , A. Israel3, A. Brom4, G. Segal4
    1. Rabin Medical Center, Division of Gastroenterology, Petah Tikva, Israel
    2. Sackler Faculty of Medicine, Tel Aviv University, Tel aviv, Israel
    3. Clalit health services, Jerusalem, Israel
    4. Sheba Medical Center affiliated with Sackler faculty of medicine Tel Aviv University, Internal Medicine T, Ramat Gan, Israel